Company records / nuvectis.com

Nuvectis Pharma

Nuvectis Pharma (nuvectis.com): no confident changes recorded yet; website history since November 2026. Homepage last checked 12 November 2026.

First recorded website

Observed 12 November 2026

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

Nuvectis Pharma (Nasdaq: NVCT) develops innovative therapies for immune complement-related conditions and oncology, including ciprocopan, NXP200 and NXP900.

current websiteHistorical capture not publicly availableLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

Companies in the same space

Other funded startups classified under “Mixed clinical-stage biotech pipelines”. This does not mean they compete directly.

Clarametyx Biosciences clarametyx.com
Aceragen aceragen.com
TrialSpark (rebranded to Formation Bio) formation.bio
HOOKIPA Pharma hookipapharma.com
Roivant Sciences roivant.com
Viridian Therapeutics viridiantherapeutics.com

Cite this record

StartupHistory, “Nuvectis Pharma” company record, https://startuphistory.org/c/nuvectis.com

Machine-readable: /c/nuvectis.com.json. How changes are found: method.